Interruption et innovation - L'impact des mesures adoptées pendant la pandémie de COVID-19 sur les populations clés et vulnérables au VIH, à la tuberculose et à l'hépatite virale en Europe de l'Est et en Asie centrale

AFEW International rapporte que même si les organisations de réduction des risques et les services de santé s'adaptent aux restrictions liées à la pandémie, la continuité de la prévention et du traitement reste affectée. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

By AFEW International

The purpose of this document, commissioned by AFEW International, is to provide an overview of the impact of the pandemic with the novel coronavirus (SARS-CoV-2) and its associated disease, COVID-19, on the continuity of prevention, treatment and care of HIV, Tuberculosis, viral hepatitis and other relevant diseases in Eastern Europe and Central Asia (EECA).

The regional scope of this report includes the countries Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Ukraine and Uzbekistan.

This report will pay special attention to the impact of measures to prevent COVID-19 on disruptions of services for key- and vulnerable populations to the diseases mentioned earlier. These key- and vulnerable populations are: people who inject drugs, sex workers, men who have sex with men, trans people, people living with HIV, people deprived of liberty like people in prison or pre-trial detention, tuberculosis patients and their contacts, labour migrants, refugees and internally displaced people.